8:15:47 AM PDT - Saturday, September 26th, 2020

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal  

By Editor - Tue Sep 15, 6:53 am

In August, Novavax signed a deal with Serum Institute, the world’s largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373, which Novavax said will bring its manufacturing capacity to over two billion doses by mid-2021.

Read more:

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal

Leave a Reply

You must sign in to post a comment.